ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Study Tests Donor T Cells Against Breast Cancer

August 29, 2003

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

April 18, 1986

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976